US Drug Recall Register
Class II · Moderate risk Terminated Initiated Oct 19, 2015 (11 years ago)

Furosemide 20 mg/mL svn Sol

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Furosemide 20 mg/mL svn Sol, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938

Recalling firm
Western Drug
Origin
AZ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0405-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Furosemide recalls

See all
Class II · Moderate risk Ongoing

Furosemide Tablets

Reason CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Leading Pharma, LLC NDC 69315-118-01 D-0486-2026
Class II · Moderate risk Ongoing

Furosemide Tablets

Reason Presence of Foreign Substance

Graviti Pharmaceuticals Private Limited NDC 64980-563-10 D-0293-2026
Class II · Moderate risk Terminated

Furosemide Tablets USP

Reason Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.

Roxane Laboratories, Inc. NDC 0054-4297-31 D-0437-2017
Class III · Low risk Terminated

FUROSEMIDE Tablets USP

Reason CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.

Boehringer Ingelheim Roxane Inc NDC 0054-4299-31 D-0012-2016